The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
Massimo Cristofanilli(Cornell University), Klaus Pantel(Universität Hamburg), Jonathan Krell(Imperial College London), Eduardo Díaz‐Rubio(Hospital Clínico San Carlos), Cristina Raimondi(Sapienza University of Rome), Jean‐Yves Pierga(Université Paris Cité), Ángela Fernández de Lascoiti(Universidad de Navarra), Daniele Generali(University of Trieste), Salvatore Grisanti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Andrew A. Davis(Northwestern University), Sofia Agelaki(University of Crete), Luc Dirix(GZA Ziekenhuizen Campus Sint-Augustinus), Annemie Rutten(GZA Ziekenhuizen Campus Sint-Augustinus), Paola Gazzaniga(Sapienza University of Rome), Rita Zamarchi(Istituto Oncologico Veneto), José Á. García-Sáenz(Hospital Clínico San Carlos), José Vidal-Martínez(Hospital Arnau de Vilanova), Laura Zorzino(IRCCS Humanitas Research Hospital), Elisabetta Munzone(Istituti di Ricovero e Cura a Carattere Scientifico), Maria Rosa Cappelletti(University of Trieste), F Meier-Stiegen(Heinrich Heine University Düsseldorf), James M. Reuben(The University of Texas MD Anderson Cancer Center), Francesca Consoli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Luís Manso(Research Institute Hospital 12 de Octubre), Maria Teresa Sandri(IRCCS Humanitas Research Hospital), Wolfgang Janni(Grace (United States)), Erich‐Franz Solomayer(Saarland University), Lorenzo Gerratana(National Cancer Institute), Alfred Rademaker(Northwestern University), Rafael Gisbert‐Criado(Hospital Arnau de Vilanova), Mario Giuliano(Regione Campania), Stefan Michiels(Institut Gustave Roussy), Eleni Politaki(University of Crete), Michail Ignatiadis(Université Libre de Bruxelles), Luc Cabel(Université de Versailles Saint-Quentin-en-Yvelines), Vicente Carañana(Hospital Arnau de Vilanova), Jorge S. Reis‐Filho(AstraZeneca (France)), Steven Van Laere(University of Antwerp), Justin Stebbing(Anglia Ruskin University), Franco Nolè(European Institute of Oncology), Camillo Almici(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Leticia De Mattos‐Arruda(Universitat Autònoma de Barcelona), Tanja Fehm(Düsseldorf University Hospital), Carlos Caldas(University of Cambridge), Lauren Darrigues(Institut Curie), Sarah‐Jane Dawson(The University of Melbourne), Dieter Peeters(University of Antwerp), Dimitriοs Mavroudis(University of Crete), François‐Clément Bidard(Inserm)
Cited by 268
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k